|
EspAddText
EspRemoveText
|
Canadian Medical Association submission to the Standing Senate Committee on Banking, Trade and Commerce: Higher rate now: Why excise tax on tobacco is long overdue for an increase
|
Parliamentary submission
|
2014
|
|
EspAddText
EspRemoveText
|
CMA’s Recommendations for Bill S-5: An Act to amend the Tobacco Act and the Non-smokers’ Health Act and to make consequential amendments to other Acts
|
Parliamentary submission
|
2017
|
|
EspAddText
EspRemoveText
|
CMA’s Recommendations for Bill S-5 An Act to amend the Tobacco Act and the Non-smokers’ Health Act and to make consequential amendments to other Acts
|
Parliamentary submission
|
2018
|
|
EspAddText
EspRemoveText
|
Complementary and alternative medicine (update 2015)
|
Policy document
|
2015
|
|
EspAddText
EspRemoveText
|
Consultation on proposed front-of-package labelling
|
Response to consultation
|
2018
|
|
EspAddText
EspRemoveText
|
Consultation on the renewal of Federal Tobacco Control Strategy
|
Response to consultation
|
2017
|
|
EspAddText
EspRemoveText
|
Health Canada consultation on tobacco products regulations (plain and standardized appearance)
|
Response to consultation
|
2018
|
|
EspAddText
EspRemoveText
|
Health Canada’s Consultation on “Plain and Standardized Packaging”
|
Response to consultation
|
2016
|
|
EspAddText
EspRemoveText
|
Implementation of National Pharmacare
|
Response to consultation
|
2018
|
|
EspAddText
EspRemoveText
|
Insite: CMA submission regarding Insite supervised injection site and program.
|
Court submission
|
2011
|
|
EspAddText
EspRemoveText
|
Regulation of Self-Care Products in Canada
|
Response to consultation
|
2016
|
|
EspAddText
EspRemoveText
|
Regulatory framework for the mandatory reporting of adverse drug reactions and medical device incidents by provincial and territorial healthcare institutions.
|
Response to consultation
|
2016
|
|
EspAddText
EspRemoveText
|
Statement to the House of Commons Committee on Health addressing the opioid crisis in Canada
|
Parliamentary submission
|
2016
|
|
EspAddText
EspRemoveText
|
Tamper Resistance under the Controlled Drugs and Substances Act
|
Response to consultation
|
2014
|